CLSI M2 A10 : 10ED 2008

Abstract
Committee Membership
Foreword
Summary of Major Changes in This Document
Summary of CLSI Processes for Establishing Interpretive
Criteria and QC Ranges
CLSI References Methods vs Commercial Methods and CLSI
vs FDA Breakpoints (interpretive criteria)
Subcommittee on Antimicrobial Susceptibility Testing
Mission Statement
1 Scope
2 Introduction
3 Standard Precautions
4 Terminology
5 Indications for Performing Susceptibility Tests
6 Selection of Antimicrobial Agents for Routine Testing
   and Reporting
7 Reagents for the Disk Diffusion Test
8 Inoculum Preparation for Disk Diffusion Tests
9 Procedure for Performing the Disk Diffusion Test
10 Fastidious Organisms
11 Organisms Requiring Special Consideration
12 Inducible Clindamycin Resistance
13 Beta-Lactamase Tests
14 Interpretation of Disk Diffusion Test Result
15 Quality Control and Quality Assurance Procedures
16 Limitations of Disk Diffusion Methods
17 Screening Tests
Appendix A - Quality Control Protocol Flow Charts
Appendix B - Preparation of Media and Reagents
Appendix C - Conditions for Disk Diffusion Antimicrobial
             Susceptibility Tests
Appendix D - Quality Control Strains for Antimicrobial
             Susceptibility Tests
Appendix E - Quality Control Strain Maintenance
Summary of Comments and Subcommittee Responses
Summary of Delegate Comments and Subcommittee Responses
The Quality Management System Approach
Related CLSI References Materials

Provides the current Clinical and Laboratory Standards Institute recommended methods for disk susceptibility testing, criteria for quality control testing, and updated tables for interpretive zone diameters.